Literature DB >> 31914803

MiR-142-3p targeting NUCKS1 inhibits proliferation and invasion of pancreatic cancer cells.

Kexiang Zhu1, Zhengcong Zhang2, Hui Zhang1, Zhengfeng Wang1, Fanghong Wang1.   

Abstract

Objective: To investigate the effects of microRNA-142-3p (miR-142-3p) on the biological characteristics of pancreatic cancer cells and its mechanism.
Methods: The expression of miR-142-3p and nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1) in pancreatic tissues and four cancer cell lines (Panc-1, BxPC-3, AsPC-1, MIA-PaCa2) were detected by Quantitative PCR (qPCR) or Western blot. The cell viability of pancreatic cancer cells was examined by MTT assay. The apoptosis of pancreatic cancer cells was measured by flow cytometry. Transwell assay was utilized to test the migration and invasion of pancreatic cancer cells. Bioinformatics analysis for miR-142-3p was conducted and the dual luciferase reporter gene assay was utilized to further validate the predicted target relationship. The protein levels of PI3K, p-AKT and T-AKT were analyzed by Western blot.
Results: The expression of miR-142-3p was down-regulated, while the expression of NUCKS1 was significantly up-regulated in pancreatic tissues and four cancer cell lines. The expression of miR-142-3p in pancreatic tissues was inversely correlated with NUCKS1 expression. Overexpression of miR-142-3p inhibited the cell viability, cell migration, and invasion, while promoted cell apoptosis of AsPC-1 and MIA-PaCa2 cells. MiR-142-3p targeted NUCKS1 and negatively regulated NUCKS1. Overexpression of miR-142-3p decreased PI3K and p-AKT expression. Up-regulation of NUCKS1 partially reversed the effects of the overexpression of miR-142-3p on the cell viability, cell apoptosis, migration and invasion, as well as PI3K and p-AKT expression in AsPC-1 and MIA-PaCa2 cells.
Conclusion: MiR-142-3p regulated the biological characteristics of pancreatic cancer cells by directly targeting NUCKS1.

Entities:  

Keywords:  NUCKS1; Pancreatic cancer; miR-142-3p

Year:  2020        PMID: 31914803     DOI: 10.1080/21691401.2019.1652629

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  7 in total

1.  NUCKS1 Promotes Proliferation, Invasion and Migration of Non-Small Cell Lung Cancer by Upregulating CDK1 Expression.

Authors:  Shufen Zhao; Baiyao Wang; Yanning Ma; Junjie Kuang; Jiyun Liang; Yawei Yuan
Journal:  Cancer Manag Res       Date:  2020-12-24       Impact factor: 3.989

2.  Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression.

Authors:  Jian Li; Leilei Liang; Lin Xiu; Jia Zeng; Yunshu Zhu; Jusheng An; Lingying Wu
Journal:  Ann Transl Med       Date:  2022-01

3.  miR-590-5p targets RMND5A and promotes migration in pancreatic adenocarcinoma cell lines.

Authors:  Sixing Chen; Yu Chen; Yao Wen; Wanwan Cai; Ping Zhu; Wuzhou Yuan; Yongqing Li; Xiongwei Fan; Yongqi Wan; Fang Li; Jian Zhuang; Zhigang Jiang; Xiushan Wu; Yuequn Wang
Journal:  Oncol Lett       Date:  2021-05-17       Impact factor: 2.967

4.  Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p.

Authors:  Ingrid Struman; Makon-Sébastien Njock; Julien Guiot; Maureen Cambier; Amandine Boeckx; Monique Henket; Olivier Nivelles; Fanny Gester; Edouard Louis; Michel Malaise; Franck Dequiedt; Renaud Louis
Journal:  Thorax       Date:  2020-08-05       Impact factor: 9.139

5.  NUCKS promotes cell proliferation and suppresses autophagy through the mTOR-Beclin1 pathway in gastric cancer.

Authors:  Erhu Zhao; Liying Feng; Longchang Bai; Hongjuan Cui
Journal:  J Exp Clin Cancer Res       Date:  2020-09-21

6.  LncRNA Lnc712 Promotes Tumorigenesis in Hepatocellular Carcinoma by Targeting miR-142-3p/Bach-1 Axis.

Authors:  Dan Cui; Caifang Ni
Journal:  Cancer Manag Res       Date:  2020-11-05       Impact factor: 3.989

7.  miR-142-3p Modulates Cell Invasion and Migration via PKM2-Mediated Aerobic Glycolysis in Colorectal Cancer.

Authors:  JunYu Ren; Wenliang Li; Guoqing Pan; Fengchang Huang; Jun Yang; Hongbin Zhang; Ruize Zhou; Ning Xu
Journal:  Anal Cell Pathol (Amst)       Date:  2021-07-13       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.